Impact of Gluten-Friendly Bread on the Metabolism and Function of In Vitro Gut Microbiota in Healthy Human and Coeliac Subjects
The main aim of this paper was to assess the in vitro response of healthy and coeliac human faecal microbiota to gluten-friendly bread (GFB). Thus, GFB and control bread (CB) were fermented with faecal microbiota in pH-controlled batch cultures. The effects on the major groups of microbiota were mon...
Saved in:
Published in | PloS one Vol. 11; no. 9; p. e0162770 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
15.09.2016
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The main aim of this paper was to assess the in vitro response of healthy and coeliac human faecal microbiota to gluten-friendly bread (GFB). Thus, GFB and control bread (CB) were fermented with faecal microbiota in pH-controlled batch cultures. The effects on the major groups of microbiota were monitored over 48 h incubations by fluorescence in situ hybridisation. Short-chain fatty acids (SCFAs) were measured by high-performance liquid chromatography (HPLC). Furthermore, the death kinetics of Lactobacillus acidophilus, Bifidobacterium animalis subsp. lactis, Staphylococcus aureus, and Salmonella Typhimurium in a saline solution supplemented with GFB or CB were also assessed. The experiments in saline solution pinpointed that GFB prolonged the survival of L. acidophilus and exerted an antibacterial effect towards S. aureus and S. Typhimurium. Moreover, GFB modulated the intestinal microbiota in vitro, promoting changes in lactobacilli and bifidobacteria members in coeliac subjects. A final multivariate approach combining both viable counts and metabolites suggested that GFB could beneficially modulate the coeliac gut microbiome; however, human studies are needed to prove its efficacy. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Conceptualization: AB AC LL EC PDA MRC MS CL. Data curation: AC AB CL. Formal analysis: AB. Funding acquisition: CL. Investigation: TBM IG LL EC PD. Methodology: AC CL. Project administration: CL. Resources: AC MRC MS CL. Supervision: AB CL AC. Validation: AB. Visualization: AB. Writing – original draft: AB AC CL. Writing – review & editing: AB CL AC MRC MS. Current address: Health Sciences Research Centre, Life Sciences Department, Whitelands College, University of Roehampton, London, United Kingdom Competing Interests: Casillo Group is a commercial source; however, it had no role in the design of the basic patent of this research (gluten friendly treatment), did not play any role in patent development as well as in the design of this research and future works. The researchers are from Public Universities (Foggia, Italy; Rohaempton, UK). None of the basic requirements of PLOS ONE have been altered by the collaboration with the funder. On behalf of all authors, I the undersigned Dr. Antonio Bevilacqua, PhD, Senior Researcher in Food Microbiology at the Laboratory of Predictive Microbiology, Department of the Science of Agriculture, Food and Environment, University of Foggia, Italy, declare that: The authors declare no competing interests. The background of this research was a patent (see references 14 and 15, respectively Italian and international files). The patent relies upon the use of microwave for the detoxification of gluten and does not focus on any of the aspects related in this paper. The patent has been further improved (see reference 18). The presence of the patents did not compromise the validity of the research as well as all ethical requirements by PLOS ONE. Finally, there is no restriction for data sharing. This does not alter our adherence to PLOS ONE policies on sharing data and materials. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0162770 |